FDA Inspects Helix3 With No Findings

The U.S. Food & Drug Administration Bioresearch Monitoring Program reports no findings following an onsite inspection of Helix3 in April 2022. These results clearly demonstrate Helix3's commitment to quality and the effectiveness of our program.


Featured Posts
Posts are coming soon
Stay tuned...
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square